EQL Pharma AB (STO: EQL) Stock Analysis & Fundamentals

EQLEQL Pharma AB

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · eqlpharma.com

25.70SEK+2.80%Mkt Cap: 70.61M $P/E: —Today

EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers prescription drugs, including h…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap70.61M $

Enterprise Value—

Revenue (TTM)3.05M $

Gross Profit15.58M $

Net Income (TTM)1.20M $

Revenue/Share1.401 USD

Last Price25.70 SEK

Fiscal Year EndMar 2026

MR QuarterMar 2018

Employees23

CountrySE

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINSE0005497732

Valuation

P/E (Trailing)—

P/E (Forward)8.32

PEG—

EV/EBITDA—

EV/Revenue—

P/S24.16

P/B2.88

EPS (TTM)-0.49

EPS (Forward)3.13

52W Range

17.389% of range108.80

52W High108.80 SEK

52W Low17.38 SEK

Profitability

Gross Margin37.64%

Oper. Margin-16.73%

EBITDA Margin1.60%

Profit Margin2.90%

ROE4.69%

ROA1.47%

Growth

Revenue Growth21.30%

Earnings Growth—

Cash Flow & Leverage

Operating CF2.71M $

CapEx (TTM)6.43M $

FCF Margin-69.16%

FCF Yield-2.98%

Net Debt—

Net Debt/EBITDA—

Balance Sheet

Debt/Equity1.72

Current Ratio2.84

Quick Ratio—

Book Value/Sh9.044 SEK

Cash/Share—

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 SEK

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating0.0 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)47.50 SEK

Upside (mean)+84.8%

Target Range47.50 SEK – 47.50 SEK

# Analysts1

Ownership

Shares Out.29.53M

Float11.75M

Insiders57.70%

Institutions18.22%

Technical

SMA 5022.97 (+11.9%)

SMA 20043.51 (-40.9%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)55.67K

Avg Vol (10d)95.38K

Technical Indicators

RSI (14)57.8

MACD0.7953

MACD Signal0.0889

MACD Hist.+0.7065

BB Upper26.97 SEK

BB Middle22.16 SEK

BB Lower17.36 SEK

BB Width43.38%

ATR (14)1.972 SEK

Vol Ratio (20d)0.41x